Ursula A. Matulonis

Epithelial ovarian cancer.

P. Sabbatini, L. Havrilesky, A. Hakam, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Berzosertib plus gemcitabine versus gemcitabine alone in platinum-resistant high-grade serous ovarian cancer: a multicentre, open-label, randomised, phase 2 trial.

E. Kohn, Su-Chun Cheng, G. Shapiro, 2020, The Lancet. Oncology.

Attitudes to chemotherapy in patients with ovarian cancer.

M. Gore, U. Matulonis, F. Dignan, 2004, Gynecologic oncology.